Stock Scorer

ZenaTech, Inc. (ZENA)

Every figure this model derived for ZENA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 7,969,908 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 5,980,366 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 33,210,192 AssetsCurrent 2025-12-31
current liabilities 14,955,764 LiabilitiesCurrent 2025-12-31
equity 67,961,451 StockholdersEquity 2025-12-31
interest expense 1,446,748 FinanceCosts 2024-12-31
ocf -35,461,668 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 1,963,605 Revenues 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ZENA on one particular measure came for.

RatioValue
cash operating margin-1178.51
current ratio2.22
current ratio reported2.22
dilution pct85.59
ev owner earnings-3.27
ev sales72.39
fcf margin-2211.83
interest cover-17.5
operating margin-1289.62
revenue growth7.43
revenue growth per share-42.11
roic-30.65
rule of 40-1282.19
sbc pct revenue0.0

Everything else this filing tags

112 more elements from ZENA's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

ElementNewestAs of PeriodsUnit
AdditionalPaidInCapital110,671,2682025-12-31 10CAD
PreferredStockSharesAuthorized100,000,0002024-12-31 3shares
LiabilitiesAndStockholdersEquity99,763,4412025-12-31 10CAD
NetCashProvidedByUsedInFinancingActivities67,462,0422025-12-31 10CAD
AssetsNoncurrent66,553,2492025-12-31 10CAD
ProceedsFromRepaymentsOfLinesOfCredit65,308,3162025-12-31 10CAD
StockholdersEquityNoteSubscriptionsReceivable56,738,2332025-12-31 10CAD
RetainedEarningsAccumulatedDeficit-53,742,1862025-12-31 10CAD
PreferredStockValue51,810,0002025-12-31 10CAD
NetIncomeLoss-45,218,0742025-12-31 10CAD
OperatingExpenses38,235,7492025-12-31 10CAD
Assets34,646,3592024-12-31 6CAD
WeightedAverageNumberOfSharesOutstandingBasic34,183,3482025-12-31 10shares
WeightedAverageNumberOfDilutedSharesOutstanding34,183,3482025-12-31 4shares
NetCashProvidedByUsedInInvestingActivities-29,315,1762025-12-31 10CAD
OperatingIncomeLoss-25,323,0272025-12-31 10CAD
CommonStockSharesOutstanding25,101,1242024-12-31 6shares
CapitalUnitsAuthorized23,000,0002024-12-31 3shares
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest21,819,3432024-12-31 9CAD
OtherNonoperatingIncomeExpense-19,877,2792025-12-31 4CAD
PreferredStockSharesOutstanding17,150,0002024-12-31 3shares
LiabilitiesNoncurrent16,846,2262025-12-31 10CAD
NotesAndLoansReceivableNetNoncurrent15,216,0492025-12-31 10CAD
CommonStockValue14,406,2662025-12-31 10CAD
LoansPayable13,566,9562025-12-31 10CAD
Liabilities12,827,0162024-12-31 6CAD
PropertyPlantAndEquipmentGross12,645,1332025-12-31 4CAD
PropertyPlantAndEquipmentNet11,692,4442025-12-31 10CAD
FiniteLivedIntangibleAssetsNet10,355,0792025-12-31 10CAD
IncreaseDecreaseInMarketableSecuritiesRestricted9,233,0292025-12-31 4CAD
AdvancesToAffiliate9,095,5452025-12-31 10CAD
MarketableSecurities9,093,8872025-12-31 4CAD
AccountsPayableAndAccruedLiabilitiesCurrent9,074,2812025-12-31 10CAD
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent8,753,6212025-12-31 10CAD
OtherGeneralAndAdministrativeExpense6,981,1122025-12-31 10CAD
OtherAssetsNoncurrent6,682,7952025-12-31 10CAD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents5,980,3662025-12-31 15CAD
ConvertibleDebt5,930,7782025-12-31 8CAD
AccountsReceivableGross4,773,6162025-12-31 2CAD
ProfitLoss-4,481,7512024-12-31 6CAD
CommunicationsAndInformationTechnology4,273,5142025-12-31 10CAD
AccountsReceivableNetCurrent4,166,8852025-12-31 10CAD
AccountsReceivableNet4,166,8852025-12-31 4CAD
ComprehensiveIncome-4,047,9032024-12-31 6CAD
Cash3,754,0752024-12-31 6CAD
LineOfCredit3,689,4572025-12-31 10CAD
ProceedsFromWarrantExercises3,321,2902025-12-31 2CAD
PrepaidExpenseNoncurrent3,282,2212025-12-31 10CAD
LongTermDebtAndCapitalLeaseObligations3,279,2702025-12-31 10CAD
ClassOfWarrantOrRightOutstanding2,995,5512024-12-31 3shares
EmployeeBenefitsAndShareBasedCompensationNoncash2,888,5032025-12-31 10CAD
StockGrantedDuringPeriodValueSharebasedCompensation-2,888,5032025-12-31 10CAD
IncreaseDecreaseInInventoryForLongTermContractsOrPrograms2,842,7942025-12-31 4CAD
InventoryNet2,842,7942025-12-31 4CAD
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities-2,520,9912025-12-31 10CAD
Goodwill2,468,7222024-12-31 6CAD
PaymentsForProceedsFromInvestments2,266,6742025-12-31 10CAD
PaymentsToAcquireOtherProductiveAssets2,245,7542025-12-31 10CAD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect2,226,2912025-12-31 10CAD
DepreciationAndAmortization2,181,7602025-12-31 10CAD
DepreciationDepletionAndAmortization2,181,7602025-12-31 10CAD
OtherAssetsCurrent2,030,7152025-12-31 10CAD
OtherEquityInterest1,800,0002024-12-31 6CAD
AccretionExpense1,764,8352025-12-31 10CAD
PreferredStockConvertibleSharesIssuable1,694,0902025-12-31 2shares
OtherSignificantNoncashTransactionValueOfConsiderationReceived11,659,3012024-12-31 6CAD
ProfessionalFees1,522,8052025-12-31 10CAD
DerivativeLiabilities1,469,6482025-12-31 4CAD
DeferredRevenue1,270,9582025-12-31 10CAD
IncreaseDecreaseInAccountsReceivable976,9772025-12-31 10CAD
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment952,6892025-12-31 4CAD
OperatingLeaseLiabilityCurrent921,0682025-12-31 10CAD
IncreaseDecreaseInOtherReceivables883,3802025-12-31 10CAD
RepaymentsOfOtherDebt834,3842025-12-31 10CAD
InsuranceFinanceIncomeExpenses-712,6522024-12-31 6CAD
AccountsAndFinancingReceivableAllowanceForCreditLoss606,7312025-12-31 2CAD
LaborAndRelatedExpense597,2122024-12-31 6CAD
Advances-522,1762024-12-31 6CAD
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-458,9072025-12-31 10CAD
GainsLossesOnExchangeDifferencesOnTranslationNetOfTax433,8482024-12-31 6CAD
OtherReserves397,0612024-12-31 6CAD
AdjustmentForAmortization373,8882025-12-31 10CAD
ProvisionForLoanLeaseAndOtherLosses368,2282025-12-31 10CAD
WarrantsAndRightsOutstanding361,0582025-12-31 10CAD
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock341,8502025-12-31 10CAD
VariableLeasePayment333,1802025-12-31 4CAD
IssuanceOfStockAndWarrantsForServicesOrClaims319,9822025-12-31 10CAD
RecognitionOfDeferredRevenue289,5932025-12-31 10CAD
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest-241,5042023-12-31 3CAD
RightofuseAssets210,5602024-12-31 6CAD
InterestPaid204,5982024-12-31 6CAD
UnrealizedGainLossOnInvestments-139,1422025-12-31 4CAD
InvestmentIncomeInterest88,4262025-12-31 10CAD
CapitalUnitsOutstanding60,0002024-12-31 3shares
ForeignCurrencyTransactionGainLossBeforeTax32,9482025-12-31 10CAD
PaymentsForProceedsFromBusinessesAndInterestInAffiliates-20,8822024-12-31 6CAD
IncreaseDecreaseInOtherAccruedLiabilities14,1222025-12-31 10CAD
ForeignExchangeLoss11,7342024-12-31 6CAD
ProceedsFromSalesOfAssetsInvestingActivities4,6302025-12-31 4CAD
AdjustmentsForUnrealisedForeignExchangeLossesGains3,1572024-12-31 6CAD
EarningsPerShareBasic-12025-12-31 10USD/shares
EarningsPerShareDiluted-12025-12-31 10USD/shares
CommonStockParOrStatedValuePerShare02024-12-31 3USD/shares
DeferredIncomeTaxesAndTaxCredits02024-12-31 6CAD
GainsLossesOnExtinguishmentOfDebt02024-12-31 6CAD
IncomeTaxExpenseBenefit02024-12-31 6CAD
NotesReceivableNet02024-12-31 6CAD
PaymentsForProceedsFromLoansReceivable02024-12-31 6CAD
ProceedsFromConvertibleDebt02025-12-31 10CAD
ProceedsFromDebtNetOfIssuanceCosts02025-12-31 10CAD
ProceedsFromIssuanceOfCommonStock02025-12-31 10CAD
GoodwillImpairmentLoss02025-12-31 4CAD

What to be careful about

What this model itself distrusts about ZENA's figures. Written by the derivation as it ran, not added afterwards.